C

케이엠제약

225430KOSDAQ기타 화학제품 제조업

51.1 / 100

Reference Date: 2026-07-24

Financial Score11.5 / 40
News Sentiment19.6 / 25
Momentum8.0 / 20
Disclosure12.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but the high debt ratio poses financial risk. Plunged 15.6% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

KEM Pharmaceuticals specializes in oral care, beauty care, and daily necessities, offering a wide range of products such as children's and adult toothpaste, shampoo, body wash, and anti-wrinkle skincare. Its flagship brands, 'Pororo Friends' and 'Kkoma Bus Taeyo,' account for approximately 33.4% of sales, with active OEM/ODM business. The company aims to expand its domestic and international distribution channels and grow into a comprehensive daily necessities company by maintaining high-quality products.

Number of Employees

63people

Average Salary

42.8M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 16.674.0Point
PBR
0.30Industry Average 1.067.0Point

Half of industry avg (excellent)

ROE
-13.04Industry Average 4.550.0Point

Well below industry avg

Debt Ratio
22.04Industry Average 8.130.0Point

2.7x industry avg (risky)

Trend 2023~20250.5 / 10 points
Revenue Growth Rate
0.5 / 3

Avg ▼4.0% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼74.7% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -10.0% (declining, 3yr)

Detailed News Sentiment

15 totalPositive 13Neutral 2Negative 0Average Sentiment Score 78.3

Detailed Momentum

52-week position5.0Point

52w mid range (43%)

Current 1,512Won52-week high 3,03552-week low 340
1-month return0.0Point

1m -15.62% (strong drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

8 totalPositive 1Neutral 7Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-07-20
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-20
  • Positive주요사항보고서(유상증자결정)2026-07-14
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-08
  • Neutral주식등의대량보유상황보고서(일반)2026-07-08